Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-cash Items (2020 - 2025)

AVITA Medical (RCEL) has disclosed Non-cash Items for 4 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 32.89% year-over-year to $5.1 million, compared with a TTM value of $5.1 million through Dec 2025, down 32.89%, and an annual FY2025 reading of $5.1 million, down 32.89% over the prior year.
  • Non-cash Items was $5.1 million for Q4 2025 at AVITA Medical, down from $7.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $7.6 million in Q4 2024 and bottomed at $1.5 million in Q4 2022.
  • Average Non-cash Items over 4 years is $3.9 million, with a median of $3.3 million recorded in 2022.
  • The sharpest move saw Non-cash Items soared 396.65% in 2024, then crashed 32.89% in 2025.
  • Year by year, Non-cash Items stood at $1.5 million in 2022, then changed by 0.0% to $1.5 million in 2023, then skyrocketed by 396.65% to $7.6 million in 2024, then plummeted by 32.89% to $5.1 million in 2025.
  • Business Quant data shows Non-cash Items for RCEL at $5.1 million in Q4 2025, $7.6 million in Q4 2024, and $1.5 million in Q4 2023.